What subset of patients (status and GFR) are potentially acceptable candidates for transplantation? -
Answers Patients with CKD and a GFR less than or equal to 20 mL/min
What are five absolute contraindications to kidney transplantation? - Answers 1. active malignancy
(except skin cancer)
2. acute infection (e.g. osteomyelitis, HIV w/measurable viral load, active HBV/HCV, etc)
3. chronically active systemic diseases (e.g. SLE, vasculitis, cirrhosis)
4. active substance abuse
5. immunological problems (i.e. donor/recipient mismatch)
What are some relative contraindications to kidney transplantation? - Answers Advanced
cardiopulmonary disease, extensive PVD, severe chronic liver disease, morbid obesity, uncontrolled
psychiatric disorder, HIV w/unmeasurable viral load, any chronic illness with a life expectancy of less
than 5 years
What are three major preoperative immunological considerations? - Answers 1. ABO compatibility
2. HLA compatibility
3. Sensitization to HLA antigens
What is likely to happen if an ABO incompatible donor kidney is transplanted? - Answers Hyperacute
rejection due to preformed antibodies
What are the three major HLA antigens measured in transplantation and which is the most important to
match? - Answers A, B, and DR. DR seems to be the most important. (Note: each individual has two
alleles of each of these, so there are a total of *six* antigens to match)
What are panel reactive antibodies (PRA)? - Answers This is a lab test done with patient serum in which
it is screened against a panel of known HLA-typed cells to measure reaction. A highly negative PRA
indicates that a patient is less likely to have a reaction to a donor kidney, while a high PRA is predictive
of a less favorable outcome.
What is a donor-specific antibody? - Answers During PRA screening, it is possible to identify specific anti-
HLA antibodies in the recipient's serum and to avoid these antibodies in choosing potential donors.
What final crossmatch techniques are used prior to transplantation? - Answers Cytotoxicity assay:
recipient serum is mixed with donor cells (e.g. peripheral blood lymphocytes, lymph node cells, etc),
complement is added, and cells are observed for death after incubation. Flow cytometry can also be
used to get a more accurate measure of reactivity.